Protecting Effects of Dexamethasone on Thymus of Rats with Severe Acute Pancreatitis

Zhang Xiping; Chen Li; Lin Miao; Tian Hua

doi:10.1155/2007/72361

. 2007 Dec 17;2007:72361. doi: 10.1155/2007/72361

Protecting Effects of Dexamethasone on Thymus of Rats with Severe Acute Pancreatitis

Zhang Xiping ^1,^*, Chen Li ², Lin Miao ³, Tian Hua ²

PMCID: PMC2234334 PMID: 18288275

Abstract

Purpose. To study the protecting effects of dexamethasone on thymus of rats with severe acute pancreatitis (SAP). Methods. The SAP rats were randomly assigned to the model group and dexamethasone-treated group, the other normal healthy rats were assigned to the sham operation group. The rat survival, thymus pathological changes, apoptotic index, as well as expression levels of NF- $κ$ B, P-selectin, Bax, Bcl-2, and Caspase-3 protein of all groups were observed, respectively, at 3 hours, 6 hours, and 12 hours. The contents of amylase and endotoxin in plasma as well as the contents of TNF- $α$ , ${PLA}_{2}$ , and NO in serum were determined. Results. There was no marked difference between the model group and treated group in survival. The contents of different indexes in blood of treated group were lower than those of the model group to various degrees at different time points. The thymus pathological score was lower in treated group than in model group at 12 hours.The treated group in Caspase-3 protein expression of thymus significantly exceeded the model group at 12 hours. The apoptotic index was significantly higher in treated group than in model group. Conclusion. Dexamethasone has protecting effects on thymus of SAP rats.

1. INTRODUCTION

Acute pancreatitis (AP) especially severe acute pancreatitis (SAP) is a dangerous acute abdomen among diseases of digestive system. In its early stage, a big amount of inflammatory mediators will be released and activated to cause excessive immune response, resulting in cascade inflammatory injury or in severe cases systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS) [1–3]. As a basic physiological mechanism of body to maintain normal morphous and function, apoptosis has been found in multiple organs in systemic SAP complications [4–6]. At present, the sound therapeutic effects of large dose of dexamethasone on SAP has been demonstrated but further study still should be conducted for its therapeutic mechanism. There are still few reports on thymus pathological changes during SAP all over the world [7]. In this experiment, the inflammatory mediators in blood, thymus apoptosis, and protein expression of NF- $κ$ B, P-selectin, Bax, Bcl-2, and Caspase-3 upon the onset of rat SAP have been studied to discuss the protecting effects of dexamethasone on SAP complicated thymus injury and its mechanism. The tissue microarray has also been applied to the pathohistological examination of pancreatitis to improve the study efficiency, which was first reported in this article around the world.

2. MATERIALS AND METHODS

2.1. Materials

Clean grade healthy male Sprague-Dawley (SD) rat in 250–300 g of body weight purchased from the Experimental Animal Center of Medical School, Zhejiang University (Hangzhou, China). Sodium taurocholate and sodium pentobarbital purchased from Sigma-Aldrich (Mo, USA). Dexamethasone injection purchased from Zhejiang Xinchang (Shaoxing, China). The full automatic biochemical analyzer was used to determine the plasma amylase level (U/L). Plasma endotoxin tachypleus amebocyte lysate kit was purchased from Shanghai Yihua Medical Science and Technology Corporation (Institute of Medical Analysis in Shanghai, China), the calculation unit for content is EU/mL. The serum nitrogen monoxidum (NO) kit was purchased from Nanjing Jiancheng Bioengineering Research Institute (Shengzhen, China), the calculation unit is $μ$ mol/L. The TNF- $α$ ELISA kit was purchased from Jingmei Bioengineering Corporation (Hangzhou, China), the calculation unit for content is pg/mL (ng/L). The serum secretory phospholipase A₂ enzyme Assay ELA kit (PLA₂) was purchased from RdD system Ins and the calculation unit is U/mL. The NF- $κ$ B, Bax, Bcl-2, and P-Selectinantibody were purchased from Santa Cruz Company (Calif, USA). Caspase-3 antibody was purchased from NeoMarkers Company (Calif, USA), DNA nick in situ end-labeling (TUNEL) kit purchased from Takara Company. The above determinations were all operated according to the instructions of the kits.

2.2. Methods

2.2.1. Animal grouping

90 clean grade healthy male SD rats were prepared into the SAP models via the improved Aho’s method [8] and randomly divided into the model group (45 rats) and dexamethasone-treated group (45 rats). Another 45 were selected to be the sham operation group. In the next step, the above groups were randomly divided into the 3hours, 6 hours, and 12 hours groups with 15 rats in each group. The dexamethasone-treated group was injected with dexamethasone injection via vena caudalis, 0.5 mg/100 g body weight and single administration 15 minutes after successful preparation of SAP model. The sham operation group after receiving abdomen opening performed pancreas and duodenum turning over and finally abdomen closing. The sham operation group and model group were injected with the saline of the same volume via vena caudalis 15 minutes after the operation [9, 10].

2.2.2. Animal model preparation

Fasting but water restraining were imposed on all rat groups 12 hours prior to the operation. The rats were anesthetized by intraperitoneal injection of 2% sodium pentobarbital (0.25 mL/100 g) after which the rats are laid and fixed, and routine shaving, disinfection, and draping were performed. Model group: after entering abdomen via median epigastrium incision, confirmed the bile-pancreatic duct and hepatic hilus common hepatic duct, disclosed the pancreas, identified the duodenal papilla inside the duodenum duct wall, and then used a No. 5 needle to drill a hole in the mesenterium avascular area. After inserting a segmental eqidural catheter into the duodenum cavity via the hole, inserted into the bile-pancreatic duct toward the direction of papilla in a retrograde way, used the microvascular clamp to nip the catheter head temporarily and meanwhile used another microvascular clamp to temporarily occlude the common hepatic duct at the confluence of hepatic duct. After connecting the eqidural catheter end with the transfusion converter, transfused 3.5% sodium taurocholate 0.1 mL/100 g by retrograde transfusion via the microinjection pump at the speed of 0.2 mL/min. Stayed for 4 minutes after injection and removed the microvascular clamp and epidural catheter. After checking for bile leakage, sutured the hole in the duodenum lateral wall. Used the disinfected cotton ball to absorb up the anesthesia on the abdominal cavity and close the abdomen [8].

2.2.3. NF- $κ$ B, P-selectin, Bax, Bcl-2, and Caspase-3 protein expression

Applied tissue microarrays to prepare thymus microarray sections; adopted streptavidin peroxidase (SP) method for immunohistochemical staining; observed the NF- $κ$ B, P-selectin, Bax, Bcl-2, and Caspase-3 protein expression of thymus under light microscope, respectively, and carried out the comprehensive assessment according to the positive cell percentage: positive cell count < 10% means ( $-$ ); positive cell count 10–20% means (+); positive cell count 20–50% means (++); positive cell count >50% means (+++) [9].

2.2.4. Apoptotic index

Applied the tissue microarrays to prepare the thymus microarray sections; Adopted DNA nick in situ end-labeling (TUNEL) technology for staining. Observed the thymus apoptotic cells and calculated apoptotic index, respectively. The TUNEL staining technique was applied to observe the changes of thymus apoptotic cells and the apoptotic indexes were calculated. Apoptotic index = apoptotic cell count/total cell count × 100% [9].

2.2.5. Pathological score standard of thymus

There was no pathological score standard of thymus around world. Therefore, we have made a quantitative scoring standard according to the thymus pathological changes of different experimental groups, see Table 1.

Table 1.

Pathological score standard of thymus.

Pathological score	Comparison of cortex and medulla thickness	Count of epithelial cell with necrosis in cortex	Count of epithelial cell with vacuole degeneration in medulla
1	Cortex is thicker or thinner than or as thick as medulla.	1–3
1.5		1–3	1–3
2		4–10
2.5		4–10	4–5
3		>10
3.5		>10	>5
4		Flaky necrosis
4.5		Flaky necrosis	>5

Open in a new tab

2.3. Observation indexes

2.3.1. Survival

Examined the rat mortality at 3 hours, 6 hours, and 12 hours after operation and calculated the survival, observed the gross changes of thymus.

2.3.2. Pathological changes

After mercy killing, rats anesthetized by sodium pentobarbital in batches, collected the thymus and fixed them according to the related requirements, observed the pathological changes of thymus after HE staining, and performed thymus pathological score according to the self made standards see Table 1.

2.3.3. Different indexes in blood

The contents of plasma amylase and endotoxin, serum NO, TNF- $α$ , and PLA₂ were determined via blood sampling from heart.

2.3.4. Different proteins expression and apoptotic index

To observe NF- $κ$ B, P-selectin, Bax, Bcl-2, and Caspase-3 protein expression and apoptotic index of thymus.

2.4. Statistical methods

The statistical analysis was conducted to the arranged experimental results by applying the SPSS11.5 software. The Kruskal-Wallis test or variance analysis (only applied to PLA₂) was applied to the three group comparison. The Bonfferoni test was also applied to comparison. There are statistical significances when P < .05.

3. RESULTS

3.1. Survival

Model group: mortality, respectively, was 0% (0/15), 0% (0/15), and 13.33% (2/15) at 3 hours, 6 hours, and 12 hours while survival was 86.67% all along. The sham operation group and dexamethasone-treated group survived at all time points with 100% survival while there was no marked difference between the model group and dexamethasone-treated group (P > .05) [8–10].

3.2. Comparison of plasma amylase content

The model group and dexamethasone-treated group significantly exceeded the sham operation group at all time points (P < .001). No marked difference between the dexamethasone-treated groupand model group at 3 hours and 6 hours (P > .05). The dexamethasone-treated group was significantly less than the model group at 12 hours (P < .01), see Table 2.

Table 2.

Comparison of contents of different indexes in blood ( $M (Q_{R})$ ).

Groups index	Sham operation			Model			Dexamethasone-treated group
Groups index	3 h	6 h	12 h	3 h	6 h	12 h	3 h	6 h	12 h
Amylase (U/L)	2038 (346)	2117 (324)	1725 (434)	7423 (2275)	8149 (1540)	9195 (1298)	6739 (2310)	7839 (2258)	7791 (1863)
Endotoxin (EU/mL)	0.015 (0.007)	0.015 (0.007)	0.016 (0.005)	0.035 (0.017)	0.055 (0.025)	0.059 (0.020)	0.030 (0.014)	0.040 (0.012)	0.042 (0.018)
NO ( $μ$ mol/L)	10.0 (12.5)	15.0 (7.5)	15.0 (10.0)	72.5 (17.5)	62.5 (27.5)	70.0 (13.75)	50.0 (20)	60.0 (12.5)	45.0 (17.5)
TNF- $α$ (ng/L)	3.30 (3.60)	4.90 (2.60)	3.70 (2.30)	46.13 (37.95)	77.54 (42.16)	67.30 (32.13)	38.40 (26.60)	58.30 (26.40)	38.70 (28.5)

Open in a new tab

3.3. Comparison of plasma endotoxin content

The model group and dexamethasone-treated group significantly exceeded the sham operation group at all time points (P < .001). No marked difference between the dexamethasone-treated group and model group at 3 hours (P > .05). The dexamethasone-treated group was significantly less than the model group at 6 hours and 12 hours (P < .01), see Table 2.

3.4. Comparison of serum NO content

The model group and dexamethasone-treated group significantly exceeded the sham operation group at all time points (P < .001). The dexamethasone-treated group was significantly less than the model group at 3 hours and 12 hours (P < .01), see Table 2.

3.5. Comparison of serum TNF- $α$ content

The model group and dexamethasone-treated group significantly exceeded the sham operation group at all time points (P < .001). No marked difference between the dexamethasone-treated group and model group at 3 hours (P > .05). The dexamethasone-treated group was significantly less than the model group at 6 hours and 12 hours (P < .05), see Table 2.

3.6. Comparison of serum PLA₂ content

Table 3.

Comparison of PLA₂ in serum ( $\bar{X} \pm S$ ).

Groups	3 h	6 h	12 h
Sham operation group	$18.70 \pm 4.40$	$16.70 \pm 3.83$	$18.52 \pm 11.31$
Model group	$103.69 \pm 20.82$	$119.85 \pm 17.74$	$121.29 \pm 17.01$
Dexamethasone-treated group	$53.96 \pm 15.40$	$67.75 \pm 27.95$	$65.27 \pm 26.21$

Open in a new tab

3.7. Pathological changes of thymus under light microscope of all groups

3.7.1. Sham operation group

In sham operation group, histological findings of thymus at 3 hours, 6 hours, and 12 hours are consistent, thymus structure is normal, boundary between cortex and medulla is clear, cortex/medulla thickness ratio is around 2 ~1 : 1, lobule visible, envelope is intact, epithelial cell is with “starry sky” changes scattered in cortex, condensed deep purple-blue cell nucleus; many slightly stained epithelial reticular cells in star shape and with multiple protuberances, with big nucleus and rich kytoplasm in medulla; medulla structure is more loose than cortex, few epithelial cell nucleus slightly stained, and some epithelial cell “vacuole like”.

3.7.2. Model group

In model group, thymus cortex gradually thinned at 3 hours, 6 hours, and 12 hours, “starry sky” like epithelial cells with fragmented nucleus, fewer lymphocytes, slightly stained epithelial cell nucleus in medulla, and more chromatin-losing cells “vacuole like” than in normal group.

3.7.3. Dexamethasone-treated group

In treated group, cortex slightly thinned, more “starry sky” like cortex epithelial cells than in normal group, much less lymphocytes, and many “vacuole like” epithelial cells in medulla.

3.8. Comparison of thymus pathological scores of all groups

The scores were higher in model group and treated group than in sham operation groupat different time points (P < .001). The score was lower in treated group than in model group at 12 hours (P < .05), see Table 4.

Table 4.

Comparison of pathological score of the thymus ( $M (Q_{R})$ ).

Groups	3 h	6 h	12 h
Sham operation group	0.0 (1.0)	0.0 (2.0)	0.0 (1.0)
Model group	2.0 (0.0)	2.5 (2.0)	3.0 (1.5)
Dexamethasone-treated group	2.0 (1.5)	2.5 (1.0)	2.5 (0.5)

Open in a new tab

3.9. Changes of different proteins expression

The expression of NF- $κ$ B, P-selectin, Bax, and Bcl-2 in thymus was negative in all groups at different time points, see Figure 1.

Treated group: 12 hours; NF- $κ$ B × 200.

3.10. Comparison of thymus apoptosis counts of all groups

Lymphocytes were apoptotic cells of thymus. In sham operation group, apoptotic cells were found, respectively, in 2 and 1 rat at 6 hours and 12 hours, and the apoptotic index was between 10 per 10000 and 24 per 10000 as shown in Figures 2 and 3. In model group, apoptotic cells were found in 2 rats at 12 hours, and the apoptotic index was between 6 per 10000 and 8 per 10000 as shown in Figure 4. In treated group, apoptotic cells were found, respectively, in 6, 9, and 8 rats at 3 hours, 6 hours, and 12 hours, and the apoptotic index was between 2 per 10000 and 76 per 10000 as shown in Figures 5 and 6. The counts were higher in treated group than in sham operation group and model group at different time points (P < .05). There was no marked difference between model group and sham operation group (P > .05), see Table 5.

Sham operation group: 6 hours; Tunel × 200.

Sham operation group: 12 hours; Tunel × 200.

Table 5.

Comparison of apoptosis index of the thymus ( $M (Q_{R})$ ).

Group	3 h	6 h	12 h
Sham operation group	0.00 (0.00)	0.00 (0.00)	0.00 (0.00)
Model group	0.00 (0.00)	0.00 (0.00)	0.00 (0.00)
Dexamethasone-treated group	0.00 (0.06)	0.06 (0.12)	0.02 (0.30)

Open in a new tab

3.11. Comparision of Caspase-3 protein of thymus of all groups

The dexamethasone-treated group significantly exceeded the sham operation group at different time points (P < .01). The model group significantly exceeded the sham operation group at 3 hours and 6 hours (P < .05). The dexamethasone-treated group significantly exceeded the model group at 12 hours (P < .05), see Tables 6 and 7, and Figures 7–10.

Table 6.

Expression of Caspase-3 protein of the thymus.

Group	Time (h)	Cases	Pathologic grade
Group	Time (h)	Cases	$-$	+	++	+++
Sham operation group	3	15
	6	15	15
	12	15	15

Model group	3	15	10	5
	6	15	10	5
	12	13	10	3

Treated group	3	15	8	7
	6	15	6	9
	12	15	5	10

Open in a new tab

Table 7.

Comparision of Caspase-3 protein of the thymus ( $M (Q_{R})$ ).

Group	3h	6h	12h
Sham operation group	0.00 (0.00)	0.00 (0.00)	0.00 (0.00)
Model group	0.00 (1.00)	0.00 (1.00)	0.00 (0.00)
Treated group	0.00 (1.00)	1.00 (1.00)	1.00 (1.00)

Open in a new tab

Sham operation group: 12 hours; Caspase-3 × 200.

Treated group: 6 hours; Caspase-3 × 200.

3.12. Correlation analysis

The amylase of the model group was positively correlated with PLA₂ at 3 hours (P < .05). The amylase of the model group was positively correlated with NO at 6 hours (P < .05). The NO of the dexamethasone-treated group was positively correlated with PLA₂ (P < .05) and apoptotic indexes were negatively correlated with PLA₂ at 3 hours (P < .05). The TNF- $α$ content of the dexamethasone-treated group was positively correlated with PLA₂ at 6 hours (P < .05). Apoptotic indexes of the dexamethasone-treated group were negatively correlated with PLA₂ at 12 hours (P < .05).

4. DISCUSSIONS

When SAP occurs, pancreatins such as trypsin, pancrelipase, and amylopsin will be activated and excessively released [11], resulting in necrosis of pancreas and tissues around it. The absorbed necrotic tissue and bulk toxic substances will cause severe systemic inflammatory reaction. The inflammatory mediators are TNF- $α$ , PLA₂, NO, endotoxin, and so on. As one of the final common mediators in cascade reaction of inflammatory mediators [12], NO can be regarded as a study index for the changes of SAP state. TNF- $α$ which is an important cytokine participates in SAP inflammatory cascade reaction [13, 14]. In SAP cases, endotoxin may reach tissues such as lung and liver due to intestinal mucosa damage [15]. The abnormal release and activation of PLA₂ are closely related with SAP severity, and the PLA₂ inhibitor can improve the pathological changes of SAP [16, 17]. The activation of NF- $κ$ B, which is a transcription factor participating in the regulation of inflammatory molecule expression and regulates inflammatory mediator expression, is the key initial step of inflammatory reaction [18, 19]. P-Selectin is a member of the family of cell adhesion molecule and is expressed in most architectonic blood vessels of the normal human body. However, the content is very low and the expression can be significantly increased when in acute inflammation [20, 21]. It is also an important indicator of inflammation [20, 22]. This study found that NF- $κ$ B and P-selectin were negative in all groups and showed that they were not related to the inflammatory reaction of thymus in SAP rats.

In this experiment, the plasma endotoxin content and contents of NO, TNF- $α$ , and PLA₂ in serum were all lower in treated group than in model group, and were negatively correlated with thymus pathological changes, demonstrating a close relation between SAP severity and content of inflammatory mediators.

Playing an important role in the onset, progression, and prognosis of AP, apoptosis can be categorized into gene-regulated and nongene-regulated apoptosis. There are direct and indirect gene regulations. Bax and Bcl-2 are two important components of the apoptosis regulation system, but in this experiment, Bax and Bcl-2 were negative and not irrelevant to apoptosis of thymus. Caspase-3 is one of the important proteases which can induce apoptosis and is also the final effect factor of the caspase cascade effect which is involved in apoptosis, and moreover it is at the core position in the process of cutting protease cascade. Caspase-3 is a marker of apoptosis and it is also the performer of apoptosis. It can destroy a variety of protease complex in cells with the digestive way and activate intranuclear nuclease to cause the DNA schizolysis form the DNA fragments, to undermine cell calcium pump function, to lead to the situation of intracellular calcium overload, and so on [23, 24]. Inhibiting Caspase-3 activity can reduce the occurrence possibility of apoptosis [25]. In this study, we found that the level of thymus Caspase-3 protein expression in the treated group was significantly greater than that of the model group at 12 hours. It is shown that the role of dexamethasone inducing thymus apoptosis may be relevant to expression of Caspase-3 protein in SAP.

In addition to be significant in inducing the indirect gene regulation of apoptosis, inflammatory mediators are important apoptosis participants during AP and their roles are nonneglectable. These cytoactive molecules are TNF- $α$ , TGF, IL, NO, OFR, and so on [26–30]. In this experiment, the content of inflammatory mediators was lower in treated group than in model group, and the apoptotic index was higher in treated group than in model group indicating that apoptosis can be promoted by reducing the expression of inflammatory mediators.

Thymus as an important immunoregulation organ plays an important role in SIRS and MODS due to SAP. In this experiment, the expression of inflammatory mediators was lower in treated group than in model group, consistent with the pathological severity of thymus and negatively correlated with thymus apoptosis count, which demonstrated the protecting effects of apoptosis on thymus. Therefore, the author believes that just like those findings in SAP pancreas [31, 32] study, when necrosis and apoptosis coexist, the protecting effect can be achieved by inducing apoptosis if necrosis prevails. Both necrosis and apoptosis are death modes of injured cells [33]. What makes apoptosis substantially different from necrosis is that apoptosis will not release the harmful substance in lysosome or cause intense inflammatory reaction [34].

In AP/SAP, glucocorticoid (represented by dexamethasone) mainly inhibits the generation and/or effect of inflammatory mediators, enhances physical stress, improves microcirculation, alleviates endotoxemia, eliminates free radicals, and inhibits NO and NF- $κ$ B [35–37]. Dong et al. [38, 39] have found early that large dose of dexamethasone can more effectively treat SAP. In this experiment, large dose of dexamethasone has been administered. At present, the capacity of dexamethasone to induce thymus apoptosis has been confirmed [40–43]. According to the study on SIRS and MODS, thymus apoptosis or proliferation will cause immune function disorder [44]. We believe that the excessive immune response can be depressed by reducing immunocytes to inhibit the release of inflammatory mediators. Therefore, SAP complications can be alleviated by dexamethasone through induction of thymus apoptosis.

The method of sodium taurocholate injection through biliopancreatic duct to induce SAP rat model was first reported by Aho et al. [45]. It is a classic model preparation method extensively applied by the world researchers. We have found in practice [38] that ideal SAP rat models can be induced by 3.5% sodium taurocholate injected by minipump after retrograde puncturation of segmental eqidural cathete via duodenal papilla. This method features mild wound, convenient operation, and high achievement ratio.

It was found in this study that the rat survival was higher in treated group than in model group, the pathological changes were milder in treated group than in model group, and the apoptotic index was higher in treated group than in model group (P < .05), which demonstrates that dexamethasone can promote the apoptosis of thymus and protect it. It was found in the experiment that the thymus apoptosis count of treated group was positively correlated with PLA₂ and the expression of amylase, NO, and TNF- $α$ was also positively correlated with PLA₂, which suggests that dexamethasone can alleviate thymus injury by lowering PLA₂ content in SAP circulatory blood, inhibiting the secretion of amylase, and promoting the generation of cytokines such as TNF- $α$ and NO as well as thymus apoptosis. The endotoxin was lower in treated group than model group, which demonstrates that dexamethasone might inhibit the excessive systemic inflammatory reaction and indirectly induce apoptosis to improve the thymus injury of SAP rats. It can be figured out that dexamethasone did not induce thymus apoptosis through regulating NF- $κ$ B, P-selectin, Bax, and Bcl-2 of thymus since their expressions were negative at different time points.

Tissue microarray, featuring high-throughput, multiple samples as well as being economical and time saving, error reduction, convenient for empirical control design, and capable for combining with other biological technologies [46], has been extensively applied to fields such as oncopathology and drug study [47–49]. The tissue microarray has been used for the pathological examination of pancreatitis study for the first time in this experiment. We have used a tissue microarray section machine to make holes 2.0 mm in diameter on receptor paraffin block, and we have combined supersensitive SP immunohistochemical method, TUNEL, and other techniques to determine the protein expressions of Bax, Bcl-2, and NF- $κ$ B genes of thymus cells as well as apoptosis counts. The satisfying results demonstrate that tissue sample of 2.0 mm diameter can lead to reliable and highly representative experimental results. It is also energy-, time-, and reagent-saving, convenient for control, and so on.

Treated group: 3 hours; Caspase-3 × 200.

ACKNOWLEDGMENTS

This work is supported by technological foundation project of Traditional Chinese Medicine Science of Zhejiang province (no. 2003C130; no. 2004C142), foundation project for medical science and technology of Zhejiang province (no. 2003B134), grave foundation project for technological and development of Hangzhou (no. 2003123B19), intensive foundation project for technology of Hangzhou (no. 2004Z006), foundation project for medical science and technology of Hangzhou (no. 2003A004), and foundation project for technology of Hangzhou (no. 2005224).

References

1.Ueda T, Takeyama Y, Yasuda T, et al. Significant elevation of serum interleukin-18 levels in patients with acute pancreatitis. Journal of Gastroenterology. 2006;41(2):158–165. doi: 10.1007/s00535-005-1735-4. [DOI] [PubMed] [Google Scholar]
2.Uehara S, Gothoh K, Handa H, Tomita H, Tomita Y. Immune function in patients with acute pancreatitis. Journal of Gastroenterology and Hepatology. 2003;18(4):363–370. doi: 10.1046/j.1440-1746.2003.02979.x. [DOI] [PubMed] [Google Scholar]
3.Zhang J-X, Dang S-C, Qu J-G, Wang X-Q, Chen G-Z. Changes of gastric and intestinal blood flow, serum phospholipase A2 and interleukin-1 $β$ in rats with acute necrotizing pancreatitis. World Journal of Gastroenterology. 2005;11(23):3578–3581. doi: 10.3748/wjg.v11.i23.3578. [DOI] [PMC free article] [PubMed] [Google Scholar]
4.Takeyama Y. Significance of apoptotic cell death in systemic complications with severe acute pancreatitis. Journal of Gastroenterology. 2005;40(1):1–10. doi: 10.1007/s00535-004-1505-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
5.Wang X, Wang B, Wu K, Xu M, Gong Z. Growth hormone downregulated the excessive apoptosis of ileal intestinal epithelial cells in rats during the early course of acute necrotizing pancreatitis. Pancreas. 2002;25(2):205–209. doi: 10.1097/00006676-200208000-00016. [DOI] [PubMed] [Google Scholar]
6.Cheng S, Song MM, Li ZH, He SG. The protective role of gadolinium chloride in lung injury associated with acute necrotizing pancreatitis. Zhonghua Wai Ke Za Zhi. 2004;42(15):936–939. [PubMed] [Google Scholar]
7.Takeyama Y, Nishikawa J, Ueda T, Hori Y. Thymic atrophy caused by thymocyte apoptosis in experimental severe acute pancreatitis. Journal of Surgical Research. 1998;78(2):97–102. doi: 10.1006/jsre.1998.5360. [DOI] [PubMed] [Google Scholar]
8.Zhang X, Ye Q, Jiang X-G, et al. Preparation method of an ideal model of multiple organ injury of rat with severe acute pancreatitis. World Journal of Gastroenterology. 2007;13(34):4566–4573. doi: 10.3748/wjg.v13.i34.4566. [DOI] [PMC free article] [PubMed] [Google Scholar]
9.Zhang X, Chen L, Hu Q-F, et al. Effects of large dose of dexamethasone on inflammatory mediators and pancreatic cell apoptosis of rats with severe acute pancreatitis. World Journal of Gastroenterology. 2007;13(41):5506–5511. doi: 10.3748/wjg.v13.i41.5506. [DOI] [PMC free article] [PubMed] [Google Scholar]
10.Zhang X, Zhang L, Wang Y, et al. Study of the protective effects of dexamethasone on multiple organ injury in rats with severe acute pancreatitis. Journal of the Pancreas. 2007;8(4):400–412. [PubMed] [Google Scholar]
11.Saĭdalikhodzhaeva OZ, Iuldashev NM, Daniiarov AN, Muratova UZ. Pancreatic enzyme activity in early phases of acute experimental pancreatitis in rats. Ross Fiziol Zh Im I M Sechenova. 2002;88(4):526–529. [PubMed] [Google Scholar]
12.Um SH, Kwon YD, Kim CD, et al. The role of nitric oxide in experimental cerulein induced pancreatitis. Journal of Korean Medical Science. 2003;18(4):520–526. doi: 10.3346/jkms.2003.18.4.520. [DOI] [PMC free article] [PubMed] [Google Scholar]
13.Gulcubuk A, Altunatmaz K, Sonmez K, et al. Effects of curcumin on tumour necrosis factor- $α$ and interleukin-6 in the late phase of experimental acute pancreatitis. Journal of Veterinary Medicine A. 2006;53(1):49–54. doi: 10.1111/j.1439-0442.2006.00786.x. [DOI] [PubMed] [Google Scholar]
14.Kerekes L, Antal-Szalmás P, Dezso B, et al. In vitro examination of the influence of lipase and amylase on dog's pancreas tissue incubated with endotoxins, phospholipase A2 or cytokines. Magyar Sebeszet. 2005;58(2):120–124. [PubMed] [Google Scholar]
15.Vasilescu C, Herlea V, Buttenschoen K, Beger HG. Endotoxin translocation in two models of experimental acute pancreatitis. Journal of Cellular and Molecular Medicine. 2003;7(4):417–424. doi: 10.1111/j.1582-4934.2003.tb00244.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
16.Aufenanger J, Samman M, Quintel M, Fassbender K, Zimmer W, Bertsch T. Pancreatic phospholipase A2 activity in acute pancreatitis: a prognostic marker for early identification of patients at risk. Clinical Chemistry and Laboratory Medicine. 2002;40(3):293–297. doi: 10.1515/CCLM.2002.046. [DOI] [PubMed] [Google Scholar]
17.Tomita Y, Kuwabara K, Furue S, et al. Effect of a selective inhibitor of secretory phospholipase A2, S-5920/LY315920Na, on experimental acute pancreatitis in rats. Journal of Pharmacological Sciences. 2004;96(2):144–154. doi: 10.1254/jphs.fp0040314. [DOI] [PubMed] [Google Scholar]
18.Vaquero E, Gukovsky I, Zaninovic V, Gukovskaya AS, Pandol SJ. Localized pancreatic NF- $κ$ B activation and inflammatory response in taurocholate-induced pancreatitis. American Journal of Physiology. 2001;280(6):G1197–G1208. doi: 10.1152/ajpgi.2001.280.6.G1197. [DOI] [PubMed] [Google Scholar]
19.Long J, Song N, Liu X-P, Guo K-J, Guo R-X. Nuclear factor- $κ$ B activation on the reactive oxygen species in acute necrotizing pancreatitic rats. World Journal of Gastroenterology. 2005;11(27):4277–4280. doi: 10.3748/wjg.v11.i27.4277. [DOI] [PMC free article] [PubMed] [Google Scholar]
20.Lundberg AH, Granger DN, Russell J, et al. Quantitative measurement of P- and E-selectin adhesion molecules in acute pancreatitis: correlation with distant organ injury. Annals of Surgery. 2000;231(2):213–222. doi: 10.1097/00000658-200002000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
21.Kameda H, Morita I, Handa M, et al. Re-expression of functional P-selectin molecules on the endothelial cell surface by repeated stimulation with thrombin. British Journal of Haematology. 1997;97(2):348–355. doi: 10.1046/j.1365-2141.1997.522700.x. [DOI] [PubMed] [Google Scholar]
22.Ushiyama S, Laue TM, Moore KL, Erickson HP, McEver RP. Structural and functional characterization of monomeric soluble P-selectin and comparison with membrane P-selectin. Journal of Biological Chemistry. 1993;268(20):15229–15237. [PubMed] [Google Scholar]
23.Hénaff M, Antoine S, Mercadier JJ, Coulombe A, Hatem SN. The voltage-independent B-type ${Ca}^{2 +}$ channel modulates apoptosis of cardiac myocytes. The FASEB Journal. 2002;16(1):99–101. doi: 10.1096/fj.01-038fje. [DOI] [PubMed] [Google Scholar]
24.Li H, Kolluri SK, Gu J, et al. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science. 2000;289(5482):1159–1164. doi: 10.1126/science.289.5482.1159. [DOI] [PubMed] [Google Scholar]
25.Nuñez G, Benedict MA, Hu Y, Inohara N. Caspases: the proteases of the apoptotic pathway. Oncogene. 1998;17(25):3237–3245. doi: 10.1038/sj.onc.1202581. [DOI] [PubMed] [Google Scholar]
26.Malka D, Vasseur S, Bödeker H, et al. Tumor necrosis factor $α$ triggers antiapoptotic mechanisms in rat pancreatic cells through pancreatitis-associated protein I activation. Gastroenterology. 2000;119(3):816–828. doi: 10.1053/gast.2000.16491. [DOI] [PubMed] [Google Scholar]
27.Nagashio Y, Ueno H, Imamura M, et al. Inhibition of transforming growth factor $β$ decreases pancreatic fibrosis and protects the pancreas against chronic injury in mice. Laboratory Investigation. 2004;84(12):1610–1618. doi: 10.1038/labinvest.3700191. [DOI] [PubMed] [Google Scholar]
28.Leindler L, Morschl É, László F, et al. Importance of cytokines, nitric oxide, and apoptosis in the pathological process of necrotizing pancreatitis in rats. Pancreas. 2004;29(2):157–161. doi: 10.1097/00006676-200408000-00011. [DOI] [PubMed] [Google Scholar]
29.Peng Y, Gallagher SF, Haines K, Baksh K, Murr MM. Nuclear factor- $κ$ B mediates Kupffer cell apoptosis through transcriptional activation of Fas/FasL. Journal of Surgical Research. 2006;130(1):58–65. doi: 10.1016/j.jss.2005.07.030. [DOI] [PubMed] [Google Scholar]
30.Chvanov M, Petersen OH, Tepikin A. Free radicals and the pancreatic acinar cells: role in physiology and pathology. Philosophical Transactions of the Royal Society B. 2005;360(1464):2273–2284. doi: 10.1098/rstb.2005.1757. [DOI] [PMC free article] [PubMed] [Google Scholar]
31.Pei HH, Liu R-L, Jiang C-Q, Ma LL, Fang X-Y. Influence of emodin on pancreatitic acinar cell apoptosis in rats with acute pancreatitis. Journal of Bengbu Medical College. 2005;30(2):112–113. (Chinese). [Google Scholar]
32.Pei HH, Dai W, Zhou J. Effects of somatostatin on apoptosis of pancreatitic acinar cell apoptosis in acute necrotizing pancreatitis in rats. Guangdong Medical Journal. 2004;25(2):138–140. (Chinese). [Google Scholar]
33.Hahm K-B, Kim J-H, You B-M, et al. Induction of apoptosis with an extract of Artemisia asiatica attenuates the severity of cerulein-induced pancreatitis in rats. Pancreas. 1998;17(2):153–157. doi: 10.1097/00006676-199808000-00007. [DOI] [PubMed] [Google Scholar]
34.Samuilov VD, Oleskin AV, Lagunova EM. Programmed cell death. Biochemistry. 2000;65(8):873–887. [PubMed] [Google Scholar]
35.Sugiyama Y, Kato S, Abe M, Mitsufuji S, Takeuchi K. Different effects of dexamethasone and the nitric oxide synthase inhibitor L-NAME on caerulein-induced rat acute pancreatitis, depending on the severity. Inflammopharmacology. 2005;13(1–3):291–301. doi: 10.1163/156856005774423728. [DOI] [PubMed] [Google Scholar]
36.Wang Z-F, Pan C-E, Lu Y, Liu S-G, Zhang G-J, Zhang X. The role of inflammatory mediators in severe acute pancreatitis and regulation of glucocorticoids. Hepatobiliary and Pancreatic Diseases International. 2003;2(3):458–462. [PubMed] [Google Scholar]
37.Paszt A, Takács T, Rakonczay Z, et al. The role of the glucocorticoid-dependent mechanism in the progression of sodium taurocholate-induced acute pancreatitis in the rat. Pancreas. 2004;29(1):75–82. doi: 10.1097/00006676-200407000-00059. [DOI] [PubMed] [Google Scholar]
38.Dong R, Wang ZF, Lv Y, Ma QJ. Treatment of severe acute pancreatitis with large dosage of dexamethsone in the earlier time. Journal of Hepatobiliary Surgery. 2005;13(1):58–60. (Chinese). [Google Scholar]
39.Dong R, Wang ZF, Lv Y, Pan CE. Treatment of severe acute pancreatitis with large dosage of dexamethsone in rats. Chinese Journal of General Surgery. 2001;10(4):309–311. (Chinese). [Google Scholar]
40.Iwamori M, Iwamori Y. Changes in the glycolipid composition and characteristic activation of GM3 synthase in the thymus of mouse after administration of dexamethasone. Glycoconjugate Journal. 2005;22(3):119–126. doi: 10.1007/s10719-005-0363-9. [DOI] [PubMed] [Google Scholar]
41.Bruscoli S, Di Virgilio R, Donato V, et al. Genomic and non-genomic effects of different glucocorticoids on mouse thymocyte apoptosis. European Journal of Pharmacology. 2006;529(1–3):63–70. doi: 10.1016/j.ejphar.2005.10.053. [DOI] [PubMed] [Google Scholar]
42.Wang D, Müller N, McPherson KG, Reichardt HM. Glucocorticoids engage different signal transduction pathways to induce apoptosis in thymocytes and mature T cells. Journal of Immunology. 2006;176(3):1695–1702. doi: 10.4049/jimmunol.176.3.1695. [DOI] [PubMed] [Google Scholar]
43.Hajtò T, Berki T, Pàlinkàs L, Boldizsàr F, Németh P. Effects of mistletoe extract on murine thymocytes in vivo and on glucocorticoid-induced cell count reduction. Forschende Komplementärmedizin. 2006;13(1):22–27. doi: 10.1159/000090265. [DOI] [PubMed] [Google Scholar]
44.Sun Y, Lu JY, Wang XH, Lang Y, Li L. Pathologic changes of thymic dendritic cells in mouse MODS model induced by zymosan. International Journal of Clinical and Experimental Pathology. 2005;21(1):95–99. (Chinese). [Google Scholar]
45.Aho HJ, Koskensalo SM, Nevalainen TJ. Experimental pancreatitis in the rats: sodium taurocholate-induced acute hemorrhagic pancreatitis. Scandinavian Journal of Gastroenterology. 1980;15(4):411–416. doi: 10.3109/00365528009181493. [DOI] [PubMed] [Google Scholar]
46.Tian H, Zhang X, Chen L, Feng GH. Technique improvement on traditional animal model with severe acute pancreatitis in rats. Chinese Journal of Emergency Medicine. 2005;14(3):211–214. (Chinese). [Google Scholar]
47.Parker RL, Huntsman DG, Lesack DW, et al. Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray. American Journal of Clinical Pathology. 2002;117(5):723–728. doi: 10.1309/PEF8-GL6F-YWMC-AG56. [DOI] [PubMed] [Google Scholar]
48.Zellweger T, Ninck C, Mirlacher M, et al. Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer. The Prostate. 2003;55(1):20–29. doi: 10.1002/pros.10209. [DOI] [PubMed] [Google Scholar]
49.Laprise C, Sladek R, Ponton A, Bernier MC, Hudson TJ, Laviolette M. Functional classes of bronchial mucosa genes that are differentially expressed in asthma. Journal of Histochemistry and Cytochemistry. 2004;52(1):501–507. doi: 10.1186/1471-2164-5-21. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B1] 1.Ueda T, Takeyama Y, Yasuda T, et al. Significant elevation of serum interleukin-18 levels in patients with acute pancreatitis. Journal of Gastroenterology. 2006;41(2):158–165. doi: 10.1007/s00535-005-1735-4. [DOI] [PubMed] [Google Scholar]

[B2] 2.Uehara S, Gothoh K, Handa H, Tomita H, Tomita Y. Immune function in patients with acute pancreatitis. Journal of Gastroenterology and Hepatology. 2003;18(4):363–370. doi: 10.1046/j.1440-1746.2003.02979.x. [DOI] [PubMed] [Google Scholar]

[B3] 3.Zhang J-X, Dang S-C, Qu J-G, Wang X-Q, Chen G-Z. Changes of gastric and intestinal blood flow, serum phospholipase A2 and interleukin-1 $β$ in rats with acute necrotizing pancreatitis. World Journal of Gastroenterology. 2005;11(23):3578–3581. doi: 10.3748/wjg.v11.i23.3578. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B4] 4.Takeyama Y. Significance of apoptotic cell death in systemic complications with severe acute pancreatitis. Journal of Gastroenterology. 2005;40(1):1–10. doi: 10.1007/s00535-004-1505-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B5] 5.Wang X, Wang B, Wu K, Xu M, Gong Z. Growth hormone downregulated the excessive apoptosis of ileal intestinal epithelial cells in rats during the early course of acute necrotizing pancreatitis. Pancreas. 2002;25(2):205–209. doi: 10.1097/00006676-200208000-00016. [DOI] [PubMed] [Google Scholar]

[B6] 6.Cheng S, Song MM, Li ZH, He SG. The protective role of gadolinium chloride in lung injury associated with acute necrotizing pancreatitis. Zhonghua Wai Ke Za Zhi. 2004;42(15):936–939. [PubMed] [Google Scholar]

[B7] 7.Takeyama Y, Nishikawa J, Ueda T, Hori Y. Thymic atrophy caused by thymocyte apoptosis in experimental severe acute pancreatitis. Journal of Surgical Research. 1998;78(2):97–102. doi: 10.1006/jsre.1998.5360. [DOI] [PubMed] [Google Scholar]

[B8] 8.Zhang X, Ye Q, Jiang X-G, et al. Preparation method of an ideal model of multiple organ injury of rat with severe acute pancreatitis. World Journal of Gastroenterology. 2007;13(34):4566–4573. doi: 10.3748/wjg.v13.i34.4566. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B9] 9.Zhang X, Chen L, Hu Q-F, et al. Effects of large dose of dexamethasone on inflammatory mediators and pancreatic cell apoptosis of rats with severe acute pancreatitis. World Journal of Gastroenterology. 2007;13(41):5506–5511. doi: 10.3748/wjg.v13.i41.5506. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B10] 10.Zhang X, Zhang L, Wang Y, et al. Study of the protective effects of dexamethasone on multiple organ injury in rats with severe acute pancreatitis. Journal of the Pancreas. 2007;8(4):400–412. [PubMed] [Google Scholar]

[B11] 11.Saĭdalikhodzhaeva OZ, Iuldashev NM, Daniiarov AN, Muratova UZ. Pancreatic enzyme activity in early phases of acute experimental pancreatitis in rats. Ross Fiziol Zh Im I M Sechenova. 2002;88(4):526–529. [PubMed] [Google Scholar]

[B12] 12.Um SH, Kwon YD, Kim CD, et al. The role of nitric oxide in experimental cerulein induced pancreatitis. Journal of Korean Medical Science. 2003;18(4):520–526. doi: 10.3346/jkms.2003.18.4.520. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B13] 13.Gulcubuk A, Altunatmaz K, Sonmez K, et al. Effects of curcumin on tumour necrosis factor- $α$ and interleukin-6 in the late phase of experimental acute pancreatitis. Journal of Veterinary Medicine A. 2006;53(1):49–54. doi: 10.1111/j.1439-0442.2006.00786.x. [DOI] [PubMed] [Google Scholar]

[B14] 14.Kerekes L, Antal-Szalmás P, Dezso B, et al. In vitro examination of the influence of lipase and amylase on dog's pancreas tissue incubated with endotoxins, phospholipase A2 or cytokines. Magyar Sebeszet. 2005;58(2):120–124. [PubMed] [Google Scholar]

[B15] 15.Vasilescu C, Herlea V, Buttenschoen K, Beger HG. Endotoxin translocation in two models of experimental acute pancreatitis. Journal of Cellular and Molecular Medicine. 2003;7(4):417–424. doi: 10.1111/j.1582-4934.2003.tb00244.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B16] 16.Aufenanger J, Samman M, Quintel M, Fassbender K, Zimmer W, Bertsch T. Pancreatic phospholipase A2 activity in acute pancreatitis: a prognostic marker for early identification of patients at risk. Clinical Chemistry and Laboratory Medicine. 2002;40(3):293–297. doi: 10.1515/CCLM.2002.046. [DOI] [PubMed] [Google Scholar]

[B17] 17.Tomita Y, Kuwabara K, Furue S, et al. Effect of a selective inhibitor of secretory phospholipase A2, S-5920/LY315920Na, on experimental acute pancreatitis in rats. Journal of Pharmacological Sciences. 2004;96(2):144–154. doi: 10.1254/jphs.fp0040314. [DOI] [PubMed] [Google Scholar]

[B18] 18.Vaquero E, Gukovsky I, Zaninovic V, Gukovskaya AS, Pandol SJ. Localized pancreatic NF- $κ$ B activation and inflammatory response in taurocholate-induced pancreatitis. American Journal of Physiology. 2001;280(6):G1197–G1208. doi: 10.1152/ajpgi.2001.280.6.G1197. [DOI] [PubMed] [Google Scholar]

[B19] 19.Long J, Song N, Liu X-P, Guo K-J, Guo R-X. Nuclear factor- $κ$ B activation on the reactive oxygen species in acute necrotizing pancreatitic rats. World Journal of Gastroenterology. 2005;11(27):4277–4280. doi: 10.3748/wjg.v11.i27.4277. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B20] 20.Lundberg AH, Granger DN, Russell J, et al. Quantitative measurement of P- and E-selectin adhesion molecules in acute pancreatitis: correlation with distant organ injury. Annals of Surgery. 2000;231(2):213–222. doi: 10.1097/00000658-200002000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B21] 21.Kameda H, Morita I, Handa M, et al. Re-expression of functional P-selectin molecules on the endothelial cell surface by repeated stimulation with thrombin. British Journal of Haematology. 1997;97(2):348–355. doi: 10.1046/j.1365-2141.1997.522700.x. [DOI] [PubMed] [Google Scholar]

[B22] 22.Ushiyama S, Laue TM, Moore KL, Erickson HP, McEver RP. Structural and functional characterization of monomeric soluble P-selectin and comparison with membrane P-selectin. Journal of Biological Chemistry. 1993;268(20):15229–15237. [PubMed] [Google Scholar]

[B24] 23.Hénaff M, Antoine S, Mercadier JJ, Coulombe A, Hatem SN. The voltage-independent B-type ${Ca}^{2 +}$ channel modulates apoptosis of cardiac myocytes. The FASEB Journal. 2002;16(1):99–101. doi: 10.1096/fj.01-038fje. [DOI] [PubMed] [Google Scholar]

[B23] 24.Li H, Kolluri SK, Gu J, et al. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science. 2000;289(5482):1159–1164. doi: 10.1126/science.289.5482.1159. [DOI] [PubMed] [Google Scholar]

[B25] 25.Nuñez G, Benedict MA, Hu Y, Inohara N. Caspases: the proteases of the apoptotic pathway. Oncogene. 1998;17(25):3237–3245. doi: 10.1038/sj.onc.1202581. [DOI] [PubMed] [Google Scholar]

[B26] 26.Malka D, Vasseur S, Bödeker H, et al. Tumor necrosis factor $α$ triggers antiapoptotic mechanisms in rat pancreatic cells through pancreatitis-associated protein I activation. Gastroenterology. 2000;119(3):816–828. doi: 10.1053/gast.2000.16491. [DOI] [PubMed] [Google Scholar]

[B27] 27.Nagashio Y, Ueno H, Imamura M, et al. Inhibition of transforming growth factor $β$ decreases pancreatic fibrosis and protects the pancreas against chronic injury in mice. Laboratory Investigation. 2004;84(12):1610–1618. doi: 10.1038/labinvest.3700191. [DOI] [PubMed] [Google Scholar]

[B28] 28.Leindler L, Morschl É, László F, et al. Importance of cytokines, nitric oxide, and apoptosis in the pathological process of necrotizing pancreatitis in rats. Pancreas. 2004;29(2):157–161. doi: 10.1097/00006676-200408000-00011. [DOI] [PubMed] [Google Scholar]

[B29] 29.Peng Y, Gallagher SF, Haines K, Baksh K, Murr MM. Nuclear factor- $κ$ B mediates Kupffer cell apoptosis through transcriptional activation of Fas/FasL. Journal of Surgical Research. 2006;130(1):58–65. doi: 10.1016/j.jss.2005.07.030. [DOI] [PubMed] [Google Scholar]

[B30] 30.Chvanov M, Petersen OH, Tepikin A. Free radicals and the pancreatic acinar cells: role in physiology and pathology. Philosophical Transactions of the Royal Society B. 2005;360(1464):2273–2284. doi: 10.1098/rstb.2005.1757. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B31] 31.Pei HH, Liu R-L, Jiang C-Q, Ma LL, Fang X-Y. Influence of emodin on pancreatitic acinar cell apoptosis in rats with acute pancreatitis. Journal of Bengbu Medical College. 2005;30(2):112–113. (Chinese). [Google Scholar]

[B32] 32.Pei HH, Dai W, Zhou J. Effects of somatostatin on apoptosis of pancreatitic acinar cell apoptosis in acute necrotizing pancreatitis in rats. Guangdong Medical Journal. 2004;25(2):138–140. (Chinese). [Google Scholar]

[B33] 33.Hahm K-B, Kim J-H, You B-M, et al. Induction of apoptosis with an extract of Artemisia asiatica attenuates the severity of cerulein-induced pancreatitis in rats. Pancreas. 1998;17(2):153–157. doi: 10.1097/00006676-199808000-00007. [DOI] [PubMed] [Google Scholar]

[B34] 34.Samuilov VD, Oleskin AV, Lagunova EM. Programmed cell death. Biochemistry. 2000;65(8):873–887. [PubMed] [Google Scholar]

[B35] 35.Sugiyama Y, Kato S, Abe M, Mitsufuji S, Takeuchi K. Different effects of dexamethasone and the nitric oxide synthase inhibitor L-NAME on caerulein-induced rat acute pancreatitis, depending on the severity. Inflammopharmacology. 2005;13(1–3):291–301. doi: 10.1163/156856005774423728. [DOI] [PubMed] [Google Scholar]

[B36] 36.Wang Z-F, Pan C-E, Lu Y, Liu S-G, Zhang G-J, Zhang X. The role of inflammatory mediators in severe acute pancreatitis and regulation of glucocorticoids. Hepatobiliary and Pancreatic Diseases International. 2003;2(3):458–462. [PubMed] [Google Scholar]

[B37] 37.Paszt A, Takács T, Rakonczay Z, et al. The role of the glucocorticoid-dependent mechanism in the progression of sodium taurocholate-induced acute pancreatitis in the rat. Pancreas. 2004;29(1):75–82. doi: 10.1097/00006676-200407000-00059. [DOI] [PubMed] [Google Scholar]

[B38] 38.Dong R, Wang ZF, Lv Y, Ma QJ. Treatment of severe acute pancreatitis with large dosage of dexamethsone in the earlier time. Journal of Hepatobiliary Surgery. 2005;13(1):58–60. (Chinese). [Google Scholar]

[B39] 39.Dong R, Wang ZF, Lv Y, Pan CE. Treatment of severe acute pancreatitis with large dosage of dexamethsone in rats. Chinese Journal of General Surgery. 2001;10(4):309–311. (Chinese). [Google Scholar]

[B40] 40.Iwamori M, Iwamori Y. Changes in the glycolipid composition and characteristic activation of GM3 synthase in the thymus of mouse after administration of dexamethasone. Glycoconjugate Journal. 2005;22(3):119–126. doi: 10.1007/s10719-005-0363-9. [DOI] [PubMed] [Google Scholar]

[B41] 41.Bruscoli S, Di Virgilio R, Donato V, et al. Genomic and non-genomic effects of different glucocorticoids on mouse thymocyte apoptosis. European Journal of Pharmacology. 2006;529(1–3):63–70. doi: 10.1016/j.ejphar.2005.10.053. [DOI] [PubMed] [Google Scholar]

[B42] 42.Wang D, Müller N, McPherson KG, Reichardt HM. Glucocorticoids engage different signal transduction pathways to induce apoptosis in thymocytes and mature T cells. Journal of Immunology. 2006;176(3):1695–1702. doi: 10.4049/jimmunol.176.3.1695. [DOI] [PubMed] [Google Scholar]

[B43] 43.Hajtò T, Berki T, Pàlinkàs L, Boldizsàr F, Németh P. Effects of mistletoe extract on murine thymocytes in vivo and on glucocorticoid-induced cell count reduction. Forschende Komplementärmedizin. 2006;13(1):22–27. doi: 10.1159/000090265. [DOI] [PubMed] [Google Scholar]

[B44] 44.Sun Y, Lu JY, Wang XH, Lang Y, Li L. Pathologic changes of thymic dendritic cells in mouse MODS model induced by zymosan. International Journal of Clinical and Experimental Pathology. 2005;21(1):95–99. (Chinese). [Google Scholar]

[B45] 45.Aho HJ, Koskensalo SM, Nevalainen TJ. Experimental pancreatitis in the rats: sodium taurocholate-induced acute hemorrhagic pancreatitis. Scandinavian Journal of Gastroenterology. 1980;15(4):411–416. doi: 10.3109/00365528009181493. [DOI] [PubMed] [Google Scholar]

[B46] 46.Tian H, Zhang X, Chen L, Feng GH. Technique improvement on traditional animal model with severe acute pancreatitis in rats. Chinese Journal of Emergency Medicine. 2005;14(3):211–214. (Chinese). [Google Scholar]

[B47] 47.Parker RL, Huntsman DG, Lesack DW, et al. Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray. American Journal of Clinical Pathology. 2002;117(5):723–728. doi: 10.1309/PEF8-GL6F-YWMC-AG56. [DOI] [PubMed] [Google Scholar]

[B48] 48.Zellweger T, Ninck C, Mirlacher M, et al. Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer. The Prostate. 2003;55(1):20–29. doi: 10.1002/pros.10209. [DOI] [PubMed] [Google Scholar]

[B49] 49.Laprise C, Sladek R, Ponton A, Bernier MC, Hudson TJ, Laviolette M. Functional classes of bronchial mucosa genes that are differentially expressed in asthma. Journal of Histochemistry and Cytochemistry. 2004;52(1):501–507. doi: 10.1186/1471-2164-5-21. [DOI] [PMC free article] [PubMed] [Google Scholar]

PERMALINK

Protecting Effects of Dexamethasone on Thymus of Rats with Severe Acute Pancreatitis

Zhang Xiping

Chen Li

Lin Miao

Tian Hua

Abstract

1. INTRODUCTION

2. MATERIALS AND METHODS

2.1. Materials

2.2. Methods

2.2.1. Animal grouping

2.2.2. Animal model preparation

2.2.3. NF-κB, P-selectin, Bax, Bcl-2, and Caspase-3 protein expression

2.2.4. Apoptotic index

2.2.5. Pathological score standard of thymus

Table 1.

2.3. Observation indexes

2.3.1. Survival

2.3.2. Pathological changes

2.3.3. Different indexes in blood

2.3.4. Different proteins expression and apoptotic index

2.4. Statistical methods

3. RESULTS

3.1. Survival

3.2. Comparison of plasma amylase content

Table 2.

3.3. Comparison of plasma endotoxin content

3.4. Comparison of serum NO content

3.5. Comparison of serum TNF-α content

3.6. Comparison of serum PLA2 content

Table 3.

3.7. Pathological changes of thymus under light microscope of all groups

3.7.1. Sham operation group

3.7.2. Model group

3.7.3. Dexamethasone-treated group

3.8. Comparison of thymus pathological scores of all groups

Table 4.

3.9. Changes of different proteins expression

Figure 1.

3.10. Comparison of thymus apoptosis counts of all groups

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Table 5.

3.11. Comparision of Caspase-3 protein of thymus of all groups

Table 6.

Table 7.

Figure 7.

Figure 10.

3.12. Correlation analysis

4. DISCUSSIONS

Figure 8.

Figure 9.

ACKNOWLEDGMENTS

References

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases

2.2.3. NF- $κ$ B, P-selectin, Bax, Bcl-2, and Caspase-3 protein expression

3.5. Comparison of serum TNF- $α$ content

3.6. Comparison of serum PLA₂ content